Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.92x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/E 12.19x
$28.04Latest market snapshot
Implied fair value · at QLYS's multiple
$72.59158.9% above market
2.30 ACAD EPS (TTM)×31.56x QLYS P/E=$72.59
Market $28.04Implied $72.59
QLYS · current priceP/E 31.56x
$171.68Latest market snapshot
Implied fair value · at ACAD's multiple
$66.3261.4% below market
5.44 QLYS EPS (TTM)×12.19x ACAD P/E=$66.32
Market $171.68Implied $66.32